hsa-mir-4510: Hsa-mir-4510 is a microRNA that has been identified in various studies. It is one of the co-targeting miRNAs in a study that identified 43 miRNAs, including hsa-mir-4510, that potentially play a role in certain conditions [PMC7607069]. In patients with NTG (normal tension glaucoma), hsa-mir-4510 was found to be significantly upregulated compared to controls [PMC9007941]. Additionally, hsa-mir-4510 has been predicted to target the SARS-CoV-2 genome, suggesting its potential involvement in COVID-19 disease [PMC8890551]. In another study, hsa-mir-4510 was identified as one of the miRNAs associated with 90-day mortality prediction [PMC8890551]. Furthermore, hsa-mir-4510 was found to be downregulated with a specific genotype of rs2736118 and dysregulated between adenomatous and carcinoma tissue [PMC5023115]. It was also included as one of the predictors in a random forest model for certain conditions [PMC7918779]. In terms of its biological role, hsa-mir-4510 has been associated with various targets and pathways related to different diseases such as breast cancer and head and neck squamous cell carcinoma (HNSCC) [PMC5779952] [PMC9908886] [PMC7500352]. Overall, these studies highlight the potential significance of hsa-mir-4510 in different diseases and conditions.